ISOQUINOLINYL-TRIAZOLON-KOMPLEXE

Patent europeic · EP3436447 · Stritgà

Inscripziun en il register

Numer da publicaziun
EP3436447
Numer da la dumonda
EP17719066
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
Stritgà
Scrittira da patent
Concedì
Annunzià
30-03-2017
Publitgà
06-02-2019
Concedì
14-07-2021
Stritgà
23-10-2026
Motiv
Taxa annuala betg pajada
Classas IPC
C07D 401/14 (2006.01)
A61K 31/4725 (2006.01)
A61P 29/00 (2006.01)
A61P 35/00 (2006.01)
C08B 37/16 (2006.01)
Prioritad
US 201662316520 P 31.03.2016
Dumonda PCT
PCT/US2017/025076 30.03.2017
Publicaziun PCT
WO2017/173111 05.10.2017
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 23-10-2026

    Stritgà, taxa betg pajada

    Status of protective title
    Active → Cancelled
    Cancellation date
    23.10.2026
    Cause for cancellation
    Non-payment of renewal fee

    Published in Swissreg on 23.10.2026

  2. 01-04-2025

    Next annual fee due on

    Next annual fee due on
    31.03.2025 → 31.03.2026

    Published in Swissreg on 01.04.2025

  3. 01-04-2024

    Midada

    Published in Swissreg on 01.04.2024

  4. 01-04-2023

    Midada

    Published in Swissreg on 01.04.2023

  5. 25-05-2022

    Midada

    Published in Swissreg on 25.05.2022

  6. 14-07-2021

    Concedì

    Published in Swissreg on 14.07.2021

Partidas

Possessur

Takeda Pharmaceutical Company Limited

Osaka-shi, Osaka 541-0045, JP

Inventur

ZENG, Lu

San Diego California 92121, US

CHEN, Rongliang

San Diego California 92121, US

MANAM, Padma

San Diego California 92121, US

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.